Separation of rosette formation-inducing polypeptides from the supernatant of cultures of rat thymic epithelial cell line.
Taniyama. T T; Kinoshita. Y Y; Hato. F F; Tominaga. K K; Kimura. S S; Itoh. T T
Key Findings
- A ~3 kDa peptide from rat thymic cell culture induces rosette formation in outer‑cortical thymocytes, indicating immune activation.
- Anti‑thymosin‑alpha‑1 antiserum neutralizes this activity, confirming the peptide is thymosin‑alpha‑1 or closely related.
- Medullary thymocytes do not respond, showing the effect is cell‑type specific.
Practical Outcomes
- This study supports the idea that thymosin‑alpha‑1 can modulate immune cells, but it’s an early‑stage, rat‑cell experiment. It doesn’t provide dosing, safety, or human efficacy data, so it’s not a ready‑to‑use protocol for biohackers. More human‑focused research is needed before practical self‑administration.
Summary
Scientists isolated a tiny protein from rat thymus cells that can make certain immune cells form rosettes, a sign of activation, and it appears to be thymosin‑alpha‑1 or something very similar. Blocking it with specific antibodies stopped the effect, confirming its identity. The effect was seen only in a specific type of thymus cell, not all of them.
Abstract
Four polypeptide fractions were isolated by high-pressure liquid chromatography (HPLC) from culture supernatant of rat thymic epithelial cell line (IT-45R1). Biological activity of these fractions was examined according to the capacity inducing rosette-formation between rat thymocytes and guinea pig erythrocytes. A relatively rich population of non-rosette-forming cells (non-RFC), one of targets for thymic hormones, was separated from rat thymocytes by combining rosette-formation method with differential centrifugation. Non-RFC consists of outer-cortical and medullary thymocytes. Medullary thymocytes treated with the polypeptide fraction did not differentiate into RFC. Therefore, the cells, which rosette-forming capacity was induced, seem to derive from outer-cortical area. One of the polypeptide fractions (estimated molecular weight: 3 K) possessed the activity endowing non-RFC with rosette-forming capacity. Since its molecular weight was similar to that of thymosin alpha 1, the fraction was pretreated with anti-thymosin alpha 1 antiserum. The pretreatment suppressed the activity of the fraction. Thus, the fraction must contain thymosin alpha 1 or a polypeptide possessing an antigenic determinant similar to that of thymosin alpha 1. Moreover, two of four subfractions, which were divided from the active fractions by reversed-phase HPLC, showed the biological activity.
Study Information
pubmed
1989